Hoechst Pakistan Limited

KASE:HPL Stock Report

Market Cap: PK₨24.7b

Hoechst Pakistan Past Earnings Performance

Past criteria checks 3/6

Hoechst Pakistan has been growing earnings at an average annual rate of 22%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 12.7% per year. Hoechst Pakistan's return on equity is 26.3%, and it has net margins of 6.2%.

Key information

22.0%

Earnings growth rate

22.0%

EPS growth rate

Pharmaceuticals Industry Growth20.2%
Revenue growth rate12.7%
Return on equity26.3%
Net Margin6.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Hoechst Pakistan makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KASE:HPL Revenue, expenses and earnings (PKR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2426,0061,6194,1170
30 Jun 2424,6521,7093,8780
31 Mar 2422,8941,0543,5470
31 Dec 2321,3693613,4610
30 Sep 2320,394-993,5200
30 Jun 2319,084-5443,2600
31 Mar 2318,939-4053,3740
31 Dec 2218,5601673,3650
30 Sep 2218,0067703,1150
30 Jun 2217,3346513,0060
31 Mar 2216,6878752,7140
31 Dec 2115,8819062,4440
30 Sep 2115,3508482,6560
30 Jun 2115,5621,0402,5070
31 Mar 2114,2658232,4140
31 Dec 2014,1084932,5510
30 Sep 2014,2772002,3770
30 Jun 2013,8741222,5560
31 Mar 2014,330-522,8150
31 Dec 1914,5011552,8480
30 Sep 1913,763-272,7370
30 Jun 1913,434-622,7500
31 Mar 1913,2324672,6320
31 Dec 1812,9616132,5890
30 Sep 1812,7776472,6170
30 Jun 1812,5879982,5120
31 Mar 1812,7289632,5590
31 Dec 1712,4461,0062,4950
30 Sep 1712,2101,3602,4740
30 Jun 1712,8041,3892,4010
31 Mar 1712,2791,3062,4080
31 Dec 1611,8901,0192,3940
30 Sep 1611,9065642,5030
30 Jun 1611,0751902,5900
31 Mar 1611,192-412,5260
31 Dec 1510,786662,4650
30 Sep 1510,6282512,3260
30 Jun 1510,4253282,2240
31 Mar 159,9372942,1640
31 Dec 149,9492382,0930
30 Sep 149,7252741,9420
30 Jun 149,3072431,8990
31 Mar 149,1663691,7860
31 Dec 138,7923101,6950

Quality Earnings: HPL has a high level of non-cash earnings.

Growing Profit Margin: HPL became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: HPL has become profitable over the past 5 years, growing earnings by 22% per year.

Accelerating Growth: HPL has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: HPL has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (56%).


Return on Equity

High ROE: HPL's Return on Equity (26.3%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies